bosley
- 20 Feb 2004 09:34
hewittalan6
- 12 Oct 2006 08:11
- 21312 of 27111
Kim, ths,
The Halifax offer a CFD service with a 10% margin and a minimum deposit of 1000.
Not my cup of tea, but useful to those who know how to use it!!
Alan
kimoldfield
- 12 Oct 2006 08:33
- 21313 of 27111
You are welcome ths. Thanks for that Alan; CFDs are not my cup of tea either, I can do enough damage dealing in the ordinary way!
kim
maestro
- 12 Oct 2006 08:53
- 21314 of 27111
here we go...easy money!
kimoldfield
- 12 Oct 2006 08:55
- 21315 of 27111
Just to revive the French connection, but of course there may not be any relationship to SPhere, SEO have confirmed to me that is was Calyon Corporate Investment Bank to whom yesterday's RNS related.
kim
automatic
- 12 Oct 2006 09:04
- 21316 of 27111
Dear Sir,
Thank you for your email.
As you probably know, Stanelco made a detailed comment on its rights and obligations concerning the JV agreement for Biotec in its RNS statement dated 9th Oct 2006 entitled " "Proposed Placing & Open Offer" .
It should be noted that the JV agreement between Sphere and Stanelco is subject to confidentiality restrictions and that the views and interpretations expressed in the above referenced RNS statement are those of Stanelco, not of Sphere;
For your convenience, please find an abstract below from the referenced RNS statement.
PS : Definition at end of RNS Statement : MAP = Modified Atmosphere Packaging, which enables a product's shelf life to be extended.
Regards
Marielle Cayron-His
Directrice de la Communication
Groupe SPHERE
Assistante de la Communication
Sandrine Bard
T. : +33 (0)1 53 65 23 00
Biotec is a subsidiary of Stanelco jointly-owned in equal shares with SPhere. The intellectual property in Biotecs products is owned by Biotec and its subsidiaries. Under the terms of the Joint Venture Agreement Stanelco and SPhere agreed that Biotec would manufacture all products to be manufactured pursuant to Biotecs IP and processes (Biotec Materials), but that the parties would be entitled to manufacture Biotec Materials themselves should the capacity of the joint venture be insufficient to meet their respective needs. In such event, Stanelco has the exclusive right to manufacture Biotec Materials relating to MAP.
Stanelco has developed various opportunities for the sale of Biotec products in the US which require the building of micro-manufacturing facilities in the US. Stanelco intends to exploit these opportunities in accordance with the provisions of the Joint Venture Agreement. As such, in the first instance these opportunities would be available to Biotec to the extent that Biotec, with the agreement of Stanelco and SPhere, is willing and able to construct facilities in the US to meet such demand. To the extent that Biotec is not able or willing to create sufficient capacity to meet this demand, Stanelco intends to do so itself in accordance with the provisions of the Joint Venture Agreement.
In order to exploit opportunities in the US relating to the manufacture of Biotec Materials relating to MAP, it will be necessary for Stanelco to make use of Biotecs intellectual property. The Joint Venture Agreement does not, however, explicitly create a licence for Stanelco to use Biotecs intellectual property nor does it expressly provide for SPhere to co-operate with Stanelco in order to procure that Biotec grants Stanelco the appropriate licence to use Biotecs intellectual property. Having taken confirmatory legal advice on the interpretation of the Joint Venture Agreement (on the basis, inter alia, that Biotec has insufficient capacity to meet Stanelcos requirements for Biotec Materials relating to MAP, particularly in the US, that it is unable or unwilling to build the facilities in the US to meet such requirements and the parties have or will have unsuccessfully tried to find alternative solutions to minimise the impact on Biotecs business in accordance with the provisions of the Joint Venture Agreement), Stanelco believes that there is an implicit obligation on SPhere to co-operate with Stanelco to pass a shareholder resolution directing Biotec Holding GmbH to grant the appropriate licence to Stanelco or to procure that the relevant Biotec entity does so.
There is, however, a risk that in such event SPhere will not co-operate with Stanelco in which case Stanelco would need to refer the matter to arbitration under the terms of the Joint Venture Agreement. In such event, there is also a risk that the arbitrator would find against Stanelco and would not oblige SPhere to co-operate in procuring that Biotec grants Stanelco the appropriate licence. In addition, unless and until such time as Stanelco obtains the appropriate licence from Biotec, there is a risk that the relevant Biotec entity will seek to bring an action against Stanelco for infringement of its intellectual property rights and that the German courts will uphold any such action.
10/10/2006 22:31
A communication@spmetal.com
cc
Objet seo
inqui
Tonyrelaxes
- 12 Oct 2006 09:07
- 21317 of 27111
".. are those of Stanelco, not of Sphere.. "
That means Sphere do not agree, otherwise they would not have worded it thus.
Thanks, Automatic
Tonyrelaxes
- 12 Oct 2006 09:09
- 21318 of 27111
Nice to see us above 1p.
10p next tartget?
automatic
- 12 Oct 2006 09:30
- 21319 of 27111
tony
any thoughts as to what s going to happen, do you think there will be a bid for SEO, or are SEO heading for another court case, (with Sphere)
sellsell
- 12 Oct 2006 09:31
- 21320 of 27111
apparently SEO mentioned on CNN re new age packaging.
hewittalan6
- 12 Oct 2006 09:35
- 21321 of 27111
What?? We're gonna Greenseal a load of middle aged hippie tree huggers who think they are witches in Starpol?
Gets my vote.
alfalfa
- 12 Oct 2006 09:38
- 21322 of 27111
Would it be off-beam to suggest that many of these AT purchases are shorts closing ?
Alfa.
Tonyrelaxes
- 12 Oct 2006 09:48
- 21323 of 27111
Auto
Frankly, Dunno.
Sphere could possibly just be sabre rattling, with a whinge or a valid stance.
They could also be willing it down in advance of bidding. If [as ;-) ] big news is coming very soon this would be the time as the news should rapidly increase the Market Cap.
Sphere certainly would also know about, or have a good idea of, some of what is to come - through Biotec who would have been made aware of anticipated or even reserved materials requirements from SEO for MMFs in the coming year.
maestro
- 12 Oct 2006 09:50
- 21324 of 27111
CNN news just filtering through..get in quick!
Tonyrelaxes
- 12 Oct 2006 10:08
- 21325 of 27111
Every community has one!
greekman
- 12 Oct 2006 10:24
- 21326 of 27111
Alan,
Your news item, could not fail to cheer us up.
Someone mentioned a Blackadder Script.
If SEO do go down, I will feel like Blackadder when he went over the top (1st world war episode). But if they do make me big money, I will celebrate by going out and buying the biggest turnip I can find. You have to be a Blackadder fan to follow that one.
But seriously,nice to see most of us not allowing ourselves to become too morose in the present situation.
stockdog
- 12 Oct 2006 10:36
- 21327 of 27111
So this is the plan, men. We're going to buy the most exciting IP in the world. Then - and this is the clever bit - we're going to sell half so that we can't make a decision on our own what to do with it. Dickheads!
In the end management is as important as everything else put together.
hewittalan6
- 12 Oct 2006 10:43
- 21328 of 27111
Good work, baldrick
bosley
- 12 Oct 2006 11:08
- 21329 of 27111
sd, that certainly is a cunning plan.
driver
- 12 Oct 2006 11:41
- 21330 of 27111
The Blackadder Script is now on the Research Page for all eternity.
59) The Blackadder Script.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
hewittalan6
- 12 Oct 2006 11:53
- 21331 of 27111
Driver, I am touched. Genuinely!!
Alan